{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:49:30Z","timestamp":1791899370813,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013669","name":"Ionis Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013669","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["lipidjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jacl.2025.04.190","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T15:42:19Z","timestamp":1744299739000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A qualitative study to explore the patient experience of hypertriglyceridemia-related acute pancreatitis"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9417-6637","authenticated-orcid":false,"given":"Asia Sikora","family":"Kessler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Aggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8166-8779","authenticated-orcid":false,"given":"Ellen M.","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7681-6303","authenticated-orcid":false,"given":"Daniel E.","family":"Soffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Acaster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jacl.2025.04.190_bib0001","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019343","article-title":"Coronary heart disease risk associated with primary isolated hypertriglyceridemia; a population-based study","volume":"10","author":"Saadatagah","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.jacl.2025.04.190_bib0002","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jacl.2016.03.031","article-title":"Unique discordance of LDL-C levels and apo A1\/remnant ratios in South Asians: implications for risk stratification for prevalent diabetes mellitus","volume":"10","author":"Nelson","year":"2016","journal-title":"J Clin Lipidol"},{"issue":"2","key":"10.1016\/j.jacl.2025.04.190_bib0003","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.amjcard.2010.09.010","article-title":"Patient characteristics and medical care costs associated with hypertriglyceridemia","volume":"107","author":"Nichols","year":"2011","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.jacl.2025.04.190_bib0004","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.amjcard.2010.11.008","article-title":"Prevalence of severe (500 to 2,000 mg\/dl) hypertriglyceridemia in United States adults","volume":"107","author":"Christian","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2025.04.190_bib0005","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1177\/2047487319888054","article-title":"Prevalence of familial chylomicronemia syndrome in a quaternary care center","volume":"27","author":"Pallazola","year":"2020","journal-title":"Eur J Prevent Cardiol"},{"issue":"4","key":"10.1016\/j.jacl.2025.04.190_bib0006","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/gt.2012.43","article-title":"Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial","volume":"20","author":"Gaudet","year":"2013","journal-title":"Gene Ther"},{"issue":"4","key":"10.1016\/j.jacl.2025.04.190_bib0007","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jacl.2018.03.093","article-title":"Clinical and biochemical features of different molecular etiologies of familial chylomicronemia","volume":"12","author":"Hegele","year":"2018","journal-title":"J Clin Lipidol"},{"issue":"2","key":"10.1016\/j.jacl.2025.04.190_bib0008","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.atherosclerosis.2009.05.024","article-title":"Association of moderate and severe hypertriglyceridemia with obesity, diabetes mellitus and vascular disease in the Spanish working population: results of the ICARIA study","volume":"207","author":"Valdivielso","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2025.04.190_bib0009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/4721357","article-title":"Management of hypertriglyceridemia induced acute pancreatitis","volume":"2018","author":"Garg","year":"2018","journal-title":"Biomed Res Int"},{"issue":"10","key":"10.1016\/j.jacl.2025.04.190_bib0010","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s11883-023-01140-z","article-title":"Updates in drug treatment of severe hypertriglyceridemia","volume":"25","author":"Gouni-Berthold","year":"2023","journal-title":"Curr Atheroscler Rep"},{"issue":"9","key":"10.1016\/j.jacl.2025.04.190_bib0011","doi-asserted-by":"crossref","first-page":"e3473","DOI":"10.1210\/clinem\/dgab360","article-title":"Rare variants in triglycerides-related genes increase pancreatitis risk in multifactorial chylomicronemia syndrome","volume":"106","author":"Paquette","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.jacl.2025.04.190_bib0012","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrendo.2015.26","article-title":"Chylomicronaemia\u2014current diagnosis and future therapies","volume":"11","author":"Brahm","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jacl.2025.04.190_bib0013","doi-asserted-by":"crossref","DOI":"10.1007\/s11883-021-00962-z","article-title":"Clinical management of hypertriglyceridemia in the prevention of cardiovascular disease and pancreatitis","volume":"23","author":"Hernandez","year":"2021","journal-title":"Curr Atherosclerosis Rep"},{"issue":"4","key":"10.1016\/j.jacl.2025.04.190_bib0014","doi-asserted-by":"crossref","first-page":"365","DOI":"10.4065\/mcp.2009.0535","article-title":"A \u201cHot\u201d topic in dyslipidemia management\u2014\u201chow to beat a flush\u201d: optimizing niacin tolerability to promote long-term treatment adherence and coronary disease prevention","volume":"85","author":"Jacobson","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacl.2025.04.190_sbref0015","series-title":"FDA approves drug to reduce triglycerides in adult patients with familial chylomicronemia syndrome","year":"2024"},{"issue":"19","key":"10.1016\/j.jacl.2025.04.190_bib0016","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa2400201","article-title":"Olezarsen, acute pancreatitis, and familial chylomicronemia syndrome","volume":"390","author":"Stroes","year":"2024","journal-title":"New Engl J Med"},{"issue":"6","key":"10.1016\/j.jacl.2025.04.190_bib0017","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/s41395-018-0087-7","article-title":"Recurrent acute pancreatitis significantly reduces quality of life even in the absence of overt chronic pancreatitis","volume":"113","author":"Cot\u00e9","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.jacl.2025.04.190_bib0018","article-title":"People\u2019s perceptions and experience of managing life after recurrent pancreatitis: a qualitative study in eastern China","volume":"12","author":"Chen","year":"2022","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.jacl.2025.04.190_bib0019","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/SGA.0000000000000442","article-title":"The lived experience of inpatients with acute recurrent pancreatitis","volume":"43","author":"Liu","year":"2020","journal-title":"Gastroenterol Nursing"},{"issue":"6","key":"10.1016\/j.jacl.2025.04.190_bib0020","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-060107","article-title":"Psychological experience of inpatients with acute pancreatitis: a qualitative study","volume":"12","author":"Ma","year":"2022","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.jacl.2025.04.190_bib0021","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s41669-019-0155-y","article-title":"Symptoms and dietary impact in hypertriglyceridemia-associated pancreatitis: development and content validity of two new measures","volume":"4","author":"Burbridge","year":"2020","journal-title":"PharmacoEconomics - Open,"},{"issue":"1","key":"10.1016\/j.jacl.2025.04.190_bib0022","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/gutjnl-2012-302779","article-title":"Classification of acute pancreatitis - 2012: revision of the Atlanta classification and definitions by international consensus","volume":"62","author":"Banks","year":"2013","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.jacl.2025.04.190_bib0023","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s13023-023-02927-8","article-title":"Symptoms and impacts of familial chylomicronemia syndrome: a qualitative study of the patient experience","volume":"18","author":"Williams","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jacl.2025.04.190_bib0024","doi-asserted-by":"crossref","unstructured":"Wu B.U., Butler R.K., Chen W. Factors associated with opioid use in patients hospitalized for acute pancreatitis. JAMA Netw Open. 2019;2(4). [cited 2024 Aug 14]e191827\u2013e191827. Available from: https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2730469. Accessed August 14, 2024.","DOI":"10.1001\/jamanetworkopen.2019.1827"},{"issue":"6","key":"10.1016\/j.jacl.2025.04.190_bib0025","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-060107","article-title":"Psychological experience of inpatients with acute pancreatitis: a qualitative study","volume":"12","author":"Ma","year":"2022","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.jacl.2025.04.190_bib0026","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000055793","article-title":"Body composition, physiological function and psychological changes in patients with predicted severe acute pancreatitis","volume":"1","author":"Gupta","year":"2001","journal-title":"Pancreatology"},{"issue":"4","key":"10.1016\/j.jacl.2025.04.190_bib0027","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.pan.2016.02.011","article-title":"Systematic review of hypertriglyceridemia-induced acute pancreatitis: a more virulent etiology?","volume":"16","author":"Carr","year":"2016","journal-title":"Pancreatology"},{"key":"10.1016\/j.jacl.2025.04.190_bib0028","doi-asserted-by":"crossref","unstructured":"Janssen B, Szende A. Population Norms for the EQ-5D. 2013 Sep 26. In: Szende A, Janssen B, Cabases J, editors. Self-Reported Population Health: An International Perspective based on EQ-5D [Internet]. Dordrecht (NL): Springer; 2014. Chapter 3.","DOI":"10.1007\/978-94-007-7596-1"},{"issue":"2","key":"10.1016\/j.jacl.2025.04.190_bib0029","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s11136-022-03266-0","article-title":"Qualitative development of the PROMIS profile v1.0-familial chylomicronemia Syndrome (FCS) 28","volume":"32","author":"Kaiser","year":"2023","journal-title":"Quality Life Res"},{"issue":"10","key":"10.1016\/j.jacl.2025.04.190_bib0030","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1007\/s11136-023-03446-6","article-title":"Measuring PROMIS pain interference in German patients with chronic conditions: calibration, validation, and cross-cultural use of item parameters","volume":"32","author":"Obbarius","year":"2023","journal-title":"Quality Life Res"},{"issue":"2","key":"10.1016\/j.jacl.2025.04.190_bib0031","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s40273-022-01218-7","article-title":"Estimating the relationship between EQ-5D-5L and EQ-5D-3L: results from a UK population study","volume":"41","author":"Hern\u00e1ndez Alava","year":"2022","journal-title":"Pharmacoeconomics"},{"issue":"10","key":"10.1016\/j.jacl.2025.04.190_bib0032","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Quality Life Res"},{"issue":"1","key":"10.1016\/j.jacl.2025.04.190_bib0033","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1186\/s12889-019-7623-2","article-title":"Quality of life assessment in patients with heart failure: validity of the German version of the generic EQ-5D-5LTM","volume":"19","author":"Boczor","year":"2019","journal-title":"BMC Public Health"},{"issue":"8","key":"10.1016\/j.jacl.2025.04.190_bib0034","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.jval.2011.06.014","article-title":"Content validity\u2014establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 1\u2014Eliciting concepts for a new PRO instrument","volume":"14","author":"Patrick","year":"2011","journal-title":"Value in Health"},{"key":"10.1016\/j.jacl.2025.04.190_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2021.114523","article-title":"Sample sizes for saturation in qualitative research: a systematic review of empirical tests","volume":"292","author":"Hennink","year":"2022","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.jacl.2025.04.190_bib0036","series-title":"Self-reported population health: An international perspective based on EQ-5D","first-page":"19","article-title":"Population norms for the EQ-5D","author":"Janssen","year":"2014"},{"issue":"3","key":"10.1016\/j.jacl.2025.04.190_bib0037","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/SGA.0000000000000375","article-title":"Patients\u2019 Perceptions of experiences of recovering from acute pancreatitis","volume":"42","author":"Boije","year":"2019","journal-title":"Gastroenterol Nursing"},{"key":"10.1016\/j.jacl.2025.04.190_bib0038","article-title":"New approaches to triglyceride reduction: is there any hope left?","volume":"18","author":"Filtz","year":"2024","journal-title":"Am J Prevent Cardiol"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425002685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425002685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T02:55:08Z","timestamp":1747968908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287425002685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":38,"alternative-id":["S1933287425002685"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2025.04.190","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A qualitative study to explore the patient experience of hypertriglyceridemia-related acute pancreatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2025.04.190","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of National Lipid Association.","name":"copyright","label":"Copyright"}]}}